Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Herpes Viruses Sabotage Histocompatibility Complex

By Biotechdaily staff writers
Posted on 27 Jan 2003
A recent study has found that herpes viruses avoid destruction by the immune system through a mechanism that interferes with the expression of molecules of the major histocompatibility complex (MHC) on the surface of cells. More...
The study was published in the January 2003 issue of Immunity.

Researchers from Washington University School of Medicine (St. Louis, MO, USA) found that the viral mK3 protein acted as a pseudo-chaperone molecule during the assembly of MHC class I molecules by the TAP/tapasin complex.

Tapasin is a transmembrane glycoprotein located in the endoplasmic reticulum that plays an important role in the assembly and peptide binding process of the MHC class I molecule. Tapasin is a subunit of the protein complex consisting of the transporter associated with antigen processing (TAP), MHC class I, and the chaperone molecule calreticulin. Tapasin binds to TAP1 and to beta-2 microglobulin (after beta-2 m has bound the MHC I alpha chain), thus acting as a bridge between the MHC I molecule and the TAP1/2 complex.

The viral mK3 protein joined the TAP/tapasin complex as a pseudo-chaperone molecule and labeled the MHC I molecule with ubiquitin, which marked it for destruction by cellular proteasomes. The destruction of the MHC molecule prevented expression of viral antigens on the cell surface and prevented the immune system from recognizing the herpes virus.

"These findings not only provide a better understanding of viral infections,” explained senior author Dr. Ted H. Hansen, professor of genetics at Washington University School of Medicine. "They also offer novel insights into basic cellular processes in the immune system.”



Related Links:
Washington University School of Medicine

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
All-in-One Molecular System
AIO M160
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.